Liao Yue, Li Huxiao, Shu Rong, Chen Huiwen, Zhao Liping, Song Zhongchen, Zhou Wei
Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Research Institute of Stomatology, Shanghai, China.
Front Cell Infect Microbiol. 2020 Apr 29;10:180. doi: 10.3389/fcimb.2020.00180. eCollection 2020.
The recovery of impaired periodontium is still a challenge to the treatment of periodontitis. This study was the first to apply the mesoporous hydroxyapatites/chitosan (mHA/CS) composite scaffold to periodontal regeneration. The aim of our study is to evaluate the biological effects of mesoporous hydroxyapatite/chitosan (mHA/CS) loaded with recombinant human amelogenin (rhAm) on periodontal regeneration. The physicochemical properties of mHA/CS scaffolds were examined by Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and Brunauer-Emmett-Teller (BET) analysis. Then, the biological effects of the mHA/CS loaded with rhAm were evaluated, including antibacterial effect, controlled-release capacity, osteogenic and cementogenic effects and . The antibacterial effect was tested on 1.5 mg/mL CS; 3 mg/mL mHA; 2.25 mg/mL mHA/CS; 4.5 mg/mL mHA/CS and 20 μg/mL rhAm. Tryptic Soy Broth culture medium was used as a baseline control. Osteogenic effect of rhAm (20 μg/mL rhAm), mHA/CS (4.5 mg/mL mHA/CS), and mHA/CS-rhAm (4.5 mg/mL mHA/CS and 20 μg/mL rhAm) on human periodontal ligament cells (hPDLCs) was evaluated in osteogenic media. The hPDLCs treated either with osteogenic media or Dulbecco's modified Eagle's medium (DMEM) alone were used as the baseline control. In the animal model, 4-week-old nude mice (BALB/c) ( = 6) implanted with root slices subcutaneously were used to observe the cementogenic effect . The root slices were treated with rhAm (20 μg/mL rhAm), mHA/CS (4.5 mg/mL mHA/CS), and mHA/CS-rhAm (4.5 mg/mL mHA/CS and 20 μg/mL rhAm). The root slices treated with osteogenic medium alone were used as the baseline control. The analyses showed that the mHA/CS particles were 2 μm in diameter and had a uniform pore size. The mesoporous structure was 7 nm in diameter and its surface area was 33.95 m/g. The scaffold exhibited antibacterial effects against and . The mHA/CS scaffold sustainably released rhAm. The mHA/CS loaded with 20 μg/mL rhAm upregulated ALP activity, the expression levels of osteogenesis-related genes and proteins . Additionally, it promoted the formation of cementum-like tissue . Our findings suggest that mHA/CS loaded with 20 μg/mL rhAm could inhibit the growth of periodontal pathogens and promote the formation of bone and cementum-like tissue.
牙周组织受损后的恢复仍是牙周炎治疗面临的一项挑战。本研究首次将介孔羟基磷灰石/壳聚糖(mHA/CS)复合支架应用于牙周组织再生。我们研究的目的是评估负载重组人釉原蛋白(rhAm)的介孔羟基磷灰石/壳聚糖(mHA/CS)对牙周组织再生的生物学效应。通过傅里叶变换红外光谱(FTIR)、透射电子显微镜(TEM)和布鲁诺尔-埃米特-泰勒(BET)分析检测了mHA/CS支架的物理化学性质。然后,评估了负载rhAm的mHA/CS的生物学效应,包括抗菌效果、控释能力、成骨和成牙骨质效应。在1.5mg/mL壳聚糖、3mg/mL mHA、2.25mg/mL mHA/CS、4.5mg/mL mHA/CS和20μg/mL rhAm上测试了抗菌效果。胰蛋白胨大豆肉汤培养基用作基线对照。在成骨培养基中评估了rhAm(20μg/mL rhAm)、mHA/CS(4.5mg/mL mHA/CS)和mHA/CS-rhAm(4.5mg/mL mHA/CS和20μg/mL rhAm)对人牙周膜细胞(hPDLCs)的成骨效应。单独用成骨培养基或杜尔贝科改良 Eagle 培养基(DMEM)处理的hPDLCs用作基线对照。在动物模型中,使用皮下植入根切片的4周龄裸鼠(BALB/c)(n = 6)来观察成牙骨质效应。根切片用rhAm(20μg/mL rhAm)、mHA/CS(4.5mg/mL mHA/CS)和mHA/CS-rhAm(4.5mg/mL mHA/CS和20μg/mL rhAm)处理。单独用成骨培养基处理的根切片用作基线对照。分析表明,mHA/CS颗粒直径为2μm,孔径均匀。介孔结构直径为7nm,表面积为33.95m²/g。该支架对[具体细菌名称未给出]和[具体细菌名称未给出]具有抗菌作用。mHA/CS支架可持续释放rhAm。负载20μg/mL rhAm的mHA/CS上调了碱性磷酸酶(ALP)活性、成骨相关基因和蛋白质的表达水平。此外,它促进了类牙骨质组织的形成。我们的研究结果表明,负载20μg/mL rhAm的mHA/CS可以抑制牙周病原体的生长,并促进骨和类牙骨质组织的形成。